Literature DB >> 23760586

Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.

Chan Wook Kim1, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim.   

Abstract

PURPOSE: To evaluate stage IIA colorectal cancer in terms of recurrence so as to discover whether high preoperative serum carcinoembryonic antigen (s-CEA) levels indicate that the patient should be included in a high-risk group in stage II colorectal cancer.
METHODS: We retrospectively reviewed the records of 1543 patients with stage IIA colorectal cancer who underwent curative surgery between January 2000 and December 2007.
RESULTS: The 5-year disease-free survival and overall survival rates were significantly lower in patients with a higher than normal preoperative s-CEA (90.5% vs. 82.5%, P<0.001, and 92.4% vs. 87.8%, P=0.034, respectively). Multivariate analysis revealed that elevated preoperative s-CEA level, preoperative obstruction, rectal cancer, and dissection of fewer than 12 nodes were independent statistically significant prognostic factors that predicted disease-free survival in patients with stage IIA disease after curative resection.
CONCLUSIONS: Elevated preoperative s-CEA concentration is a reliable predictor of recurrence after curative resection in patients with stage IIA colorectal cancer. Patients with stage IIA disease with elevated preoperative s-CEA level do worse than those with normal levels and might constitute a group to evaluate for adjuvant chemotherapy. Further studies on the effect of adjuvant chemotherapy in this group are needed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760586     DOI: 10.1245/s10434-013-2919-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer.

Authors:  Heita Ozawa; Kenjiro Kotake; Miki Hosaka; Akira Hirata; Yusuke Nakagawa; Shin Fujita; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2017-02-09       Impact factor: 2.571

2.  Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.

Authors:  Gota Saito; Sotaro Sadahiro; Takashi Ogimi; Hiroshi Miyakita; Kazutake Okada; Akira Tanaka; Toshiyuki Suzuki
Journal:  Oncology       Date:  2017-12-22       Impact factor: 2.935

3.  Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.

Authors:  Gota Saito; Sotaro Sadahiro; Hiroko Kamata; Hiroshi Miyakita; Kazutake Okada; Akira Tanaka; Toshiyuki Suzuki
Journal:  Oncology       Date:  2017-02-09       Impact factor: 2.935

4.  Laparoscopic versus open low anterior resection for rectal cancer: results from the national cancer data base.

Authors:  Daniel P Nussbaum; Paul J Speicher; Asvin M Ganapathi; Brian R Englum; Jeffrey E Keenan; Christopher R Mantyh; John Migaly
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

5.  Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer.

Authors:  Han-Gil Kim; Seung Yoon Yang; Yoon Dae Han; Min Soo Cho; Byung Soh Min; Kang Young Lee; Nam Kyu Kim; Hyuk Hur
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

6.  Elevated CEA is associated with worse survival in recurrent rectal cancer.

Authors:  Won Kyung Cho; Doo Ho Choi; Hee Chul Park; Won Park; Jeong Il Yu; Young Suk Park; Joon Oh Park; Ho Yeong Lim; Won Ki Kang; Hee Cheol Kim; Yong Beom Cho; Seong Hyeon Yun; Woo Yong Lee
Journal:  Oncotarget       Date:  2017-11-18

7.  Tumor location as a novel high risk parameter for stage II colorectal cancers.

Authors:  Biyuan Wang; Jiao Yang; Shuting Li; Meng Lv; Zheling Chen; Enxiao Li; Min Yi; Jin Yang
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

8.  Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.

Authors:  Shaonan Fan; Ting Li; Ping Zhou; Qiliang Peng; Yaqun Zhu
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

9.  Identification of Predictive Factors for Lymph Node Metastasis in pT1 Stage Colorectal Cancer Patients: A Retrospective Analysis Based on the Population Database.

Authors:  Jiawei Song; Huanhuan Yin; Yong Zhu; Shengqi Fei
Journal:  Pathol Oncol Res       Date:  2022-02-28       Impact factor: 3.201

10.  Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.

Authors:  Tsuyoshi Konishi; Yoshifumi Shimada; Meier Hsu; Lauren Tufts; Rosa Jimenez-Rodriguez; Andrea Cercek; Rona Yaeger; Leonard Saltz; J Joshua Smith; Garrett M Nash; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Mithat Gonen; Martin R Weiser
Journal:  JAMA Oncol       Date:  2018-03-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.